Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A1 | P30531 | 1/20 | 0.30 |
| ▸ | SLC6A12 | P48065 | 1/20 | 0.30 |
| ▸ | SLC6A11 | P48066 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28314893 | 0.76 | NR3C1 (0.35) | SLC6A1SLC6A12SLC6A11 | |
| SCHEMBL3914285 | 0.76 | NR3C1 (0.35) | SLC6A1SLC6A12SLC6A11 | |
| SCHEMBL3914283 | 0.76 | NR3C1 (0.35) | SLC6A1SLC6A12SLC6A11 | |
| SCHEMBL6944583 | 0.72 | APOBEC3A (0.30) | — | |
| SCHEMBL1176729 | 0.70 | — | — | |
| SCHEMBL28688971 | 0.69 | PLA2G1B (0.33) | SLC6A1SLC6A12SLC6A11 | |
| SCHEMBL11825501 | 0.69 | PLA2G1B (0.33) | SLC6A1SLC6A12SLC6A11 | |
| SCHEMBL8358195 | 0.66 | L3MBTL1 (0.32) | SLC6A1SLC6A12SLC6A11 | |
| SCHEMBL8358193 | 0.66 | L3MBTL1 (0.32) | SLC6A1SLC6A12SLC6A11 | |
| SCHEMBL3920696 | 0.66 | NR3C1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030203915-A1 | Nitric oxide donors, compositions and methods of use related applications | NICOX S.A. (FR) | 2003-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030203915-A1 | Nitric oxide donors, compositions and methods of use related applications | NOS1, NOS2, NOS3 | SLC6A1 1797/4885SLC6A12 2040/4885SLC6A11 1748/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.